SCHEMBL2292815

SCHEMBL2292815

O=C(CC/C(=N/O)OC(=O)c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1)OC(=O)c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
HPGD P15428 1/20 0.49
RAB9A P51151 1/20 0.49
SMPD1 P17405 2/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
LTB4R Q15722 1/20 0.41
LTB4R2 Q9NPC1 1/20 0.41
HIF1A Q16665 1/20 0.41
POLB P06746 2/20 0.40
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 2/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10861035 0.82 SMN1; SMN2 (0.63) SMN1; SMN2NPC1HPGDRAB9ASMPD1
SCHEMBL2295910 0.82 HTT (0.51) SMN1; SMN2NPC1MEN1KMT2AKDM4E
SCHEMBL10861040 0.80 SMN1; SMN2 (0.60) SMN1; SMN2NPC1HPGDRAB9ASMPD1
SCHEMBL2363669 0.78 HTT (0.42) SMN1; SMN2NPC1MEN1KMT2AKDM4E
SCHEMBL2356948 0.78 PRSS1 (0.42) RAB9AKMT2AHIF1APOLBALDH1A1
SCHEMBL5986576 0.76 CES2 (0.44) SMN1; SMN2NPC1HPGDRAB9AHDAC8
SCHEMBL6027320 0.76 ELANE (0.44) HPGDRAB9AMEN1KMT2AALDH1A1
SCHEMBL30141105 0.76 KMT2A (0.62) SMN1; SMN2NPC1HPGDRAB9ASMPD1
SCHEMBL3960907 0.76 KMT2A (0.62) SMN1; SMN2NPC1HPGDRAB9ASMPD1
SCHEMBL11286951 0.75 NPC1 (0.78) SMN1; SMN2NPC1HPGDRAB9ASMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989430-B2 Antibacterial agents REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2011-08-02 US disclosed
US-20080293666-A1 Antibacterial Agents REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2008-11-27 US disclosed
EP-1960518-A2 ANTIBACTERIAL AGENTS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2008-08-27 EP disclosed
WO-2007067559-A2 ANTIBACTERIAL AGENTS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293666-A1 Antibacterial Agents MRPL21, ABCB7, MSR1 SMN1; SMN2 4231/4885NPC1 1199/4885HPGD 2789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.